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New diagnostic reporting format for endometrial cytology based on cytoarchitectural criteria
Objective: The aim of this study was to develop a new reporting format for endometrial cytology that would
standardize the diagnostic criteria and the terminology used for reporting.
Methods: In previous studies, cytoarchitectural criteria were found to be useful for the cytological assessment of
endometrial lesions. To apply these criteria, an appropriate cytological specimen is imperative. In this article,
the requirements of an adequate endometrial cytological specimen for the new diagnostic criteria are ﬁrst
discussed. Then, the diagnostic criteria, standardized on a combination of conventional and cytoarchitectural
criteria, are presented. Third, terminology that could be used, not only for reporting the histopathological
diagnosis, but also for providing better guidance for the gynaecologist to determine further clinical action, is
introduced. The proposed reporting format was investigated using endometrial cytology of 58 cases that were
cytologically underestimated or overestimated compared to the histopathological diagnosis made on the
subsequent endometrial biopsy or surgical specimens.
Results: Of the 58 cases, 12 were reassessed as being unsatisfactory for evaluation. Among the remaining 46
cases, 25 of the 27 cases, which had been underestimated and subsequently diagnosed as having endometrial
carcinoma or a precursor stage on histopathological examination,were reassessed as recommended for
endometrial biopsy. On the other hand, 19 cases overestimated by cytology were all reassessed as not requiring
biopsy.
Conclusions: The reporting format for endometrial cytology proposed in this article may improve diagnostic
accuracy and reduce the number of patients managed inappropriately.
Keywords: cytodiagnosis, endometrial cytology, reporting format, specimen adequacy, diagnostic criteria,
architectural features
Introduction
Compared to cervical cytology, endometrial cytology
is considered unreliable, diagnostically. The main
reason for this is thought to be the inconspicuous
differences between normal and abnormal endome-
trial cells because of the small size of the cells. The
changes in the cellular features and the presence of
cell clumps during the normal menstrual cycle com-
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address these problems, there has been increasing
interest in the cytoarchitectural endometrial criteria.
However, the practical application of these criteria has
not been fully worked out. Usually, endometrial
cytology reports are classiﬁed into three groups:
negative, suspicious or positive. A presumptive histo-
pathological diagnosis may also be reported. However,
using this reporting method, many of the suspicious
cases are false positives, leading to unnecessary
biopsies. In Japan, when atypical endometrial hyper-
plasia or carcinoma is suspected on cytology, biopsies
are usually performed. On the other hand, when
normal or atrophic endometrium is reported, no
additional biopsies are required, unless carcinoma or
a precursor lesion cannot be excluded on clinical
grounds. Therefore, for the cytological diagnosis of the
endometrium, complete agreement between the
cytology and the histopathology is not essential. What
matters is whether a biopsy is necessary to establish
the ﬁnal diagnosis.
Currently, for endometrial lesions, there are several
quantitative and qualitative cytological methods that
are based on the cell collecting techniques of individ-
ual laboratories or hospitals.
1–5 However, there is no
inclusive diagnostic and reporting system for endo-
metrial cytology that has clear deﬁnitions of specimen
quality. The purpose of this study was to evaluate an
appropriate reporting format that includes a deﬁnition
of specimen and clinical information adequacy,
acceptable diagnostic criteria, and an endometrial
cytology report.
Materials and methods
At the Suzuka General Hospital, the Yamada Red
Cross Hospital, and the Yamamoto General Hospital,
12 729 endometrial cytology samples were received
between January 2002 and April 2006. Of these cases,
58 were included in this study (Table 1). All 58
specimens had been underestimated or overesti-
mated compared to the subsequent histopathological
diagnosis based on endometrial biopsy or surgical
specimens, 20 cases having been overestimated cyto-
logically and 38 cases underestimated. In this study,
the endometrial cytology obtained by direct sampling
of the endometrial cavity were prepared with Endo-
cyte (Laboratoire Ccd, Paris, France), Honestbrush N
(Honest Medical, Tokyo, Japan), or Endotube-M
(Matsudaikakougyo, Tokyo, Japan).
When Endocyte or Honestbrush N was used, the
cell sampler was rolled on a glass slide and the
material was spread and smeared. In some cases, to
transfer the cells onto the glass slide, the tip of the
brush was strongly ﬂicked with the forceps; this was
repeated several times as the brush was repositioned
along the length of the slide. When the tube was used,
the material that had been sucked into the tube was
pumped onto the glass slide. All cytological smears
were routinely ﬁxed in 95% alcohol and subsequently
stained using the standard Papanicolaou method.
Tissue samples were routinely formalin ﬁxed, parafﬁn
embedded, and processed for staining with haemat-
oxylin and eosin. The histopathological diagnoses
included 20 cases of benign endometrium, four cases
of complex hyperplasia, three cases of atypical simple
hyperplasia, six cases of atypical complex hyperplasia,
and 25 cases of endometrioid adenocarcinoma. In
each hospital, these slides were used to evaluate
endometrial lesions based on conventional criteria.
To assess our reporting system, all cytological and
histopathological slides accompanied by the relevant
clinical information were re-evaluated microscopically
by four of the authors (T.M., K.Y., Y.N., and A.K.).
Table 1. Cases undergoing cytological re-
assessment Histological diagnosis Underestimated Overestimated
Complex hyperplasia 4
Atypical simple hyperplasia 3
Atypical complex hyperplasia 6
Endometrioid adenocarcinoma 25
Benign endometrium
Proliferative endometrium 9
Secretory endometrium 4
Other 6
Endometrial polyp 1
Total 38 20
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imen was determined to be either satisfactory for
evaluation or less than optimal, it was reviewed for
cytological evaluation. The following results were
obtained with respect to the specimen adequacy
criteria and the cytological diagnosis.
Statement on specimen adequacy
Using the new reporting format, when the maximum
diameter of a cell cluster was 0.2 mm or more, it was
deﬁned as a cell clump. Specimens that were not
acceptable for diagnostic evaluation because of poor
ﬁxation, preservation, or labelling, drying of the
specimen, an obscure background, distortion of cells
or cell clumps, insufﬁcient clinical information or
scant cellularity were reported as Unsatisfactory for
evaluation (Table 2). If the ﬁndings were such that
the endometrium could be properly assessed despite
being an unsatisfactory specimen, for example, when
only a few isolated atypical cells were present in a
necrotic background or if there was a small clump
of obvious carcinoma cells, these specimens were
reported as Less than optimal. In these latter cases,
the referring clinician has to recognize that the
reported diagnosis may not be reliable. Repeated
cytology, endometrial biopsy or clinical follow-up
may be chosen depending on the clinical information.
All other specimens that had sufﬁcient quality and
quantity of material and for which adequate clinical
information was available were reported as Satisfac-
tory for evaluation.
Diagnostic criteria
Diagnostic criteria consisted of two main elements
(Table 3): the criteria that reﬂect the cytoarchitecture
and the conventional criteria (background, atypia of
cells, or cell clumps). Cell clumps were classiﬁed into
two categories: normal cell clumps and abnormal cell
clumps. The normal category included cell clumps
with a tube or sheet-shaped pattern. The abnormal
category included cell clumps with dilated or
branched patterns, branched patterns, papillotubular
patterns and irregular protrusions. In a previous paper
of by Norimatsu et al.,
6 all of these cell clump
characteristics were described. Cell clumps composed
of metaplastic cells and some irregular small projec-
tion ﬁgures, usually accompanied by condensed stro-
mal cell clusters,
7,8 were excluded from these four
categories as their diagnostic importance is not yet
clear.
Endometrial hyperplasia was suspected in speci-
mens with a total of 10 or more cell clumps and an
abnormal cell clump rate of 20–70%, provided there
was no overlap with the over 70% group. Atypical
Table 2. Unsatisfactory for evaluation
Poor ﬁxation, preservation, or labelling. Dry specimen
Obscuring by inﬂammation, blood
Distortion of cells or cell clumps at the time of cell
preparation
Lack of or insufﬁcient clinical information
age, last menstrual period (age at menopause),
genital bleeding, drug use, use of intrauterine device,
echo-sonographic ﬁndings
Scant cellularity
Total cell clumps <10 per one specimen
(Cell clump: diameter of cell clump >0.2 mm)
Table 3. Diagnostic criteria for endometrial cytology
(I) Frequency of abnormal cell clump*
Number of abnormal cell clumps
Total number of cell clumps appearing in the specimen
Endometrial hyperplasia is suspected: frequency of each abnormal cell clump in total ‡10 and abnormal cell clump ratio ‡10%
Atypical endometrial hyperplasia or carcinoma is suspected: frequency of each abnormal cell clump in total ‡10 and abnormal cell
clump ratio ‡50%
(II) Background and cellular atypia
Small cell cluster consisting of atypical cells
Isolated atypical cells
Necrotic background
Metaplastic change [squamous(morule), eosinophilic, ciliated, mucinous, clear cell]
*Exclusive of cell clumps consisting of metaplastic cells.
maximum diameter of the cell cluster <0.2 mm.
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cell clumps and an abnormal cell clump rate of more
than 70%.
9
The ﬁnal cytological diagnosis was based on a
combination of these results and the conventional
criteria.
The reporting of the endometrial cytological diagnosis
Once the specimen adequacy had been described, the
result was categorized into four groups; negative,
atypical endometrial cells of undetermined signiﬁ-
cance (AEC-US), atypical endometrial cells encom-
passing the spectrum of precursors to endometrial
malignant tumour (AEC-PEMT) and Positive. When
normal endometrium with proliferative, secretory or,
menstrual phase changes or atrophy had been iden-
tiﬁed cytologically, these cases were reported as
negative. The term AEC-US was used for cases in
which benign endometrial disease, such as endome-
trial bleeding because of ovarian dysfunction, iatro-
genic changes, or infection, was suspected. In such
cases, subsequent endometrial biopsy is usually not
recommended unless the change persists on repeat
cytology. The term AEC-PEMT was used for cases in
which a pre-malignant lesion, such as atypical endo-
metrial hyperplasia, was suspected and subsequent
biopsy was recommended, as for positive cases. All
options could include additional information suggest-
ing the histopathological diagnosis (Table 4).
Results
The results are summarized in Tables 5–7. With the
new reporting format for endometrial cytology, of the
58 cases, 12 cases including eight adenocarcinoma
cases were assessed as unsatisfactory for evaluation,
10 cases were assessed as less than optimal and 36
Table 4. A reporting system for endometrial cytology
Specimen adequacy
Satisfactory for evaluation
Less than optimal
Unsatisfactory for evaluation
Interpretation ⁄result
Negative
Proliferative or secretory phase, atrophic endometrium
AEC-US (atypical endometrial cells of undetermined signiﬁcance) Suspicious for benign endometrial disease (bleeding due to
ovarian dysfunction, iatrogenic changes, Infection), or simple endometrial hyperplasia (biopsy not recommended)
AEC-PEMT (atypical endometrial cells encompassing the spectrum of precursors to endometrial malignant tumour)
Suspicious for complex endometrial hyperplasia, simple or complex atypical endometrial hyperplasia, adenocarcinoma in situ
(biopsy recommended)
Positive
Suspicious for malignant tumour
Table 5. Assessment of specimen adequacy using the new
reporting system for endometrial cytology
Underestimated Overestimated Total
Unsatisfactory 11 1 12
Less than optimal 10 0 10
Satisfactory 17 19 36
Total 38 20 58
Table 6. Unsatisfactory for evaluation
Underestimated Overestimated Total
Obscuring inﬂammation 1 0 1
Lack of or insufﬁcient
clinical information
00 0
Scant cellularity 5 0 5
Obscuring by blood or
scant cellularity
51 6
Total 11 1 12
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the 12 cases that were assessed as unsatisfactory for
evaluation, 11 cases were previously underestimated
and one case was overestimated. All the 10 cases
assessed as less than optimal were underestimated.
Of 36 cases that were assessed as satisfactory for
evaluation, 17 cases were underestimated and 19
cases were overestimated (Table 5). For the 12 cases
found to be unsatisfactory for evaluation, additional
sampling was recommended. The most important
factor resulting in an unsatisfactory specimen was
scant cellularity (Table 6). Of the 27 cases originally
reported as negative cytologically, 25 were assessed as
positive or in the AEC-PEMT category. In these cases,
biopsy was recommended. The remaining two were
assessed as negative. One of these two cases had
atypical simple hyperplasia and the other had atypical
complex hyperplasia. Among the cases that had
previously been overestimated on the basis of endo-
metrial cytology, none was assessed as recommended
endometrial biopsy using the new system. Overall,
21 cases were assessed as biopsy not recommended;
all these cases had subsequent biopsies that
revealed normal endometrium (Table 7).
Discussion
In Japan, after a health insurance law for the elderly
was passed in 1987, endometrial cytology became a
routine method for the initial examination of endo-
metrial lesions; since then, the importance of endo-
metrial cytology has gradually become recognized. It is
rare that a sample is not collected because of sampling
difﬁculty or because of unacceptable pain for the
patient. Although endometrial cytology is now com-
monly used, it has a low diagnostic accuracy. In recent
years, it has been reported that, for the cytological
assessment of endometrial lesions, the cytoarchitec-
tural characteristics are more useful than conventional
criteria that reﬂect only cellular atypia. In previous
studies, the correlation between cytoarchitecture and
histopathological structure has been emphasized. Nor-
imatsu et al.
6 found statistically signiﬁcant differences
in the frequency of cell clumps classiﬁed according to
their cytoarchitectural characteristics among cases
with normal proliferative endometrium, endometrial
hyperplasia, atypical endometrial hyperplasia and
grade 1 endometrioid adenocarcinoma. Moreover,
Shimizu et al.
7 and Norimatsu et al.
8 reported that
endometrium with dysfunctional uterine bleeding
caused by an anovulatory cycle, which contains
endometrial glandular and stromal breakdown
(EGBD), can be distinguished from endometrial hyper-
plasia when care is taken to determine the frequency
of cell clumps classiﬁed according to their cytoarchi-
tectural characteristics and metaplastic changes. Given
these facts, a precise assessment of the cytoarchitecture
seems to be important. In addition to the quality
assessment, a quantitative assessment based on esti-
mating the frequency of each cell types cell clumps in
a specimen is important.
When using cytoarchitectural criteria and assessing
cell quantity for endometrial cytology, standardized
specimens and adequate clinical information are
necessary. In our new reporting format, ﬁrst of all,
specimen adequacy was assessed as in the Bethesda
System to serve as a guideline. In this study, the
presence of scant cellularity, obscuring inﬂammation
and blood or both were the most important factors
that resulted in unsatisfactory specimens. The sam-
pling and preparation of the specimens were per-
formed by gynaecologists who had to use the cell
collection instruments properly and transfer the
material collected onto glass slides. Recently, Fujihara
et al.
10 advocated that the ﬂick method using the
Uterobrush was suitable for observing cytoarchitec-
ture and was helpful to standardize the criteria for
direct intrauterine cell samples. We also use the brush
type instrument with the ﬂick method, as it allows a
sufﬁcient quantity and quality of the specimen to be
Table 7. Results of the new reporting
system for endometrial cytology (satis-
factory for assessment and less than
optimal specimens)
Underestimated Overestimated Total
Repeat sampling warranted 0 0 0
Positive or AEC-PEMT
(biopsy recommended)
25 0 25
Negative or AEC-US (biopsy
not recommended)
*2 19 21
Total 27 19 46
*Atypical simple hyperplasia: 1 case; Atypical complex hyperplasia: 1 case.
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must be made for each cell sampler. In the not too
distant future, the method of direct intrauterine cell
sampling is likely to be standardized so as to allow
common diagnostic criteria to be used. Furthermore,
liquid-based endometrial cytology may make it pos-
sible for a sufﬁcient quantity and quality of a sample
to be transferred onto the glass slide more easily. More
recently, Norimatsu et al.
11 and Buccoliero et al.
12
reported the successful sampling of endometrial cells
using liquid-based preparation as an efﬁcient diagnos-
tic method for excellent cellular preservation. This
method is expected to be easier in observation of cell
and cell cluster than conventional endometrial cyto-
logy. Furthermore, the technique is useful in provid-
ing material for adjunctive cytological diagnostic and
research purposes. In the foreseeable future, liquid-
based endometrial cytology must be adopted.
With this new reporting format for diagnosis in
endometrial cytology, we combined the use of the
conventional criteria with new criteria, such as the
frequency rate of cell clumps, based on cytoarchitec-
tural features. When the total number of abnormal
cell clumps observed in a specimen is 10 or more and
the abnormal cell clump rate is more than 20%, this
suggests endometrial hyperplasia. When the abnormal
cell clump rate is more than 70%, this suggests
atypical endometrial hyperplasia or endometrial car-
cinoma. All these diagnostic baseline values have been
chosen empirically and hence are open to discussion
and may be reﬁned by other investigators on the basis
of additional studies. Opinions vary as regards which
abnormal cell clump rate should be used for cytomor-
phology. Moreover, conventional criteria, such as
tumour background, cellular or nuclear atypia, small
atypical cell clusters and isolated atypical cells, are still
useful for diagnosing endometrial cytology, as there
are many cases that can be estimated correctly
without cytoarchitectural criteria. Nevertheless, diag-
nostic accuracy can be improved by applying cytoar-
chitectural criteria together with conventional
criteria. The importance of cytoarchitectural criteria
cannot be overemphasized. In practice, the diagnosis
of endometrial cytology must include these criteria.
In the literature, other diagnostic devices requiring
their own cell sampling methods have been de-
scribed.
1–5,13 However, because of the speciﬁcity and
complexity of their sampling and assessment proce-
dures, they have not been adopted. Moreover, their
accuracy for detecting endometrial carcinoma and its
precursor lesion is not satisfactory. In contrast, our
diagnostic criteria have been independently assessed
by other Japanese institutions,
14,15 which reported
increased diagnostic accuracy with their use. With all
of the laboratories in this study, we achieved an
extremely high diagnostic accuracy, as the cytological
report focused on the necessity or otherwise of doing
an endometrial biopsy. The high accuracy of the
reassessed specimens might have been affected by
the fact that this study was restricted to cases in which
the cytology was overestimated or underestimated.
A prospective study using this new reporting format
would clarify its validity. Nevertheless, the new
format provides uniform diagnostic terminology to
improve interlaboratory communications between the
laboratory and the clinician. Given our results, it
appears that use of the criteria proposed in this paper
is a valid and reproducible method for the cytological
evaluation of endometrial lesions that can avert
unnecessary endometrial biopsies.
In the results, AEC-US and AEC-PEMT were
adopted. The use of this category makes it possible
to avoid confusion about the meaning of the report.
When the cytology was consistent with benign
disease, changes due mostly to ovarian dysfunction,
including EGBD or simple endometrial hyperplasia,
then the cytological report stated that was AEC-US.
For whatever reason, as cytologists, we should avoid
the risk of AEC-US becoming a wastebasket classiﬁ-
cation encompassing various types of benign glandu-
lar changes as well as changes associated with
signiﬁcant cancer precursor lesions. A diagnosis of
AEC-US should be qualiﬁed to indicate whether a
reactive process or AEC-PEMT is more likely. To assist
the clinician in determining patient management, the
cytologist should communicate as much as possible
about the diagnosis and the differential diagnoses
under consideration. Appropriate triage strategy may
be considered. A presumptive histopathological diag-
nosis of the endometrial phase is required to make this
assessment. Usually, subsequent endometrial biopsy is
not recommended in these negative cases. When the
cytology is consistent with complex endometrial
hyperplasia, simple or complex atypical endometrial
hyperplasia or adenocarcinoma in situ, the cytological
report should state AEC-PEMT. The histopathological
diagnosis predicted by the cytology must be included
in the interpretation. In these cases, endometrial
biopsy is recommended to make the ﬁnal diagnosis
in a positive case. This new reporting format is not
concerned with cases of simple endometrial hyper-
plasia because there is no consensus on their
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alterations such as eosinophilic cell change is too
complicated to be examined in detail in this paper;
further investigation is required to resolve this issue.
Conclusion
The reporting format that has been proposed is
intended for use in medical consultation, just as the
Bethesda System is used. This format is useful for the
proper cytological assessment of endometrial lesions,
which is of great beneﬁt to patients. Implementation
of this format requires accurate and appropriate
clinical information, an adequate specimen that is
obtained in a satisfactory and standardized manner
and mutual understanding between the pathologist
and the gynaecologist. We predict that the ﬁeld of
gynaecological cytology will be of increasing interest
to cytopathologists if this reporting format becomes
the primary vehicle for communicating diagnoses to
clinicians.
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